RxDoctor Payments DataLook up a doctor →

Eric Born, DO

Family Medicine · Parchment, MINPI 1386653913

Payments from drug & device makers

$21,397in general payments, 2019–2025

Across 1,155 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Novo Nordisk$2K
  • Amgen$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Bayer$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)107$2,526
Novo Nordisk139$2,298
Amgen103$1,824
AbbVie(2 entities)140$1,770
Lilly USA, LLC69$1,246
Bayer45$1,057
Boehringer Ingelheim48$937
Johnson & Johnson(2 entities)44$923
Pfizer61$918
GSK53$859
Astellas Pharma US Inc40$822
Merck32$581
Corcept Therapeutics15$479
Sanofi-aventis U.S. LLC26$460
Xeris Pharmaceuticals, Inc.16$360
Eisai Inc.17$327
Novartis16$303
Mylan Specialty L.p.12$260
Amarin Pharma, Inc.15$239
Alkermes, Inc.3$232
Daiichi Sankyo Inc.10$218
Jazz Pharmaceuticals Inc.11$193
Otsuka America Pharmaceutical, Inc.8$161
Dexcom, Inc.8$159
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$155
Exact Sciences8$150
Biohaven Pharmaceuticals, Inc.8$145
Electromed, Inc.10$144
Takeda Pharmaceuticals U.S.A., Inc.7$114
E.r. Squibb & Sons, L.L.C.7$113
Cequr Corporation1$112
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$101
Biohaven Pharmaceutical Holding Company Ltd.4$101
Esperion Therapeutics, Inc.6$98
IBSA Pharma Inc.6$82
Abbott3$70
Nestle Healthcare Nutrition Inc.4$67
Radius Health, Inc.4$62
Ardelyx, Inc.2$56
Inspire Medical Systems, Inc.2$55
Teva Pharmaceuticals USA, Inc.3$54
Aimmune Therapeutics, Inc.2$43
Idorsia Pharmaceuticals US Inc2$38
Lundbeck LLC2$38
Hologic Sales And Service, LLC2$36
Harmony Biosciences LLC1$32
Viatris Specialty LLC1$29
Upsher-smith Laboratories LLC1$28
Dermira, Inc.1$27
Actelion Pharmaceuticals US, Inc.1$25
Axsome Therapeutics, Inc.1$25
Shire North American Group Inc2$24
Madrigal Pharmaceuticals1$23
Inari Medical, Inc.1$22
Vivaquant Inc, Dba Rhythm Express1$21
Adlon Therapeutics L.p.1$19
Bioventus LLC1$19
Endo Pharmaceuticals Inc.1$17
Currax Pharmaceuticals LLC1$17
Kowa Pharmaceuticals America, Inc.1$15

How this compares

$21,397 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Medicare billing

Part B allowed, 2024
$210,969
Medicare patients
329
Services billed
14,558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Parchment

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →